Physician

Laura Rosner, M.D.

According to 2025 Medicare claims, Laura Rosner, M.D. (NPI: 1427085752) practices family practice in the Tallahassee, FL market, with the plurality of this provider's patient population coming from Leon, FL. This provider's primary affiliated billing organization is TALLAHASSEE MEDICAL GROUP, PLLC (NPI: 1972265130; TIN: 871466300) and primary practice location at 32308-5433.

Rosner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 414 traditional Medicare patients, billed 6,531 HCPCS/CPT codes, and received $164,442 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,790 prescription claims across 611 beneficiaries totaling $215,850 in drug costs, led by Janumet Xr (Sitagliptin Phos/Metformin Hcl). DME data shows 14 claims. Open Payments data shows 1 records totaling $87. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $99,002 to $164,442. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $10,183 and ending at $25,856.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	300	4,557	$99,002
2016	304	4,798	$102,419
2017	323	5,020	$97,491
2018	328	5,381	$107,391
2019	328	5,538	$113,083
2020	321	4,606	$95,941
2021	475	5,499	$130,283
2022	301	4,877	$115,972
2023	322	5,564	$134,883
2024	414	6,531	$164,442

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	321	5,127	$242,674
2016	336	4,998	$199,910
2017	378	5,256	$204,797
2018	423	5,415	$226,357
2019	448	5,388	$255,519
2020	471	5,243	$241,810
2021	477	4,744	$202,626
2022	478	4,604	$223,562
2023	534	4,559	$234,486
2024	611	4,790	$215,850

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	49	227	$7,157
2016	30	212	$5,785
2017	14	126	$3,115
2018	12	76	$628
2019	13	50	$493
2020	13	61	$614
2021	N/R	44	$4,543
2022	N/R	23	$300
2023	N/R	15	$199
2024	N/R	14	$631

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	337	672	$83
80061	Blood test, lipids (cholesterol and triglycerides)	319	464	$13
80053	Blood test, comprehensive group of blood chemicals	334	528	$10
36415	Insertion of needle into vein for collection of blood sample	343	622	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	305	461	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Janumet Xr	Sitagliptin Phos/Metformin Hcl	53	2,823	$50,587
Januvia	Sitagliptin Phosphate	18	1,380	$24,435
Eliquis	Apixaban	21	752	$13,851
Levothyroxine Sodium	Levothyroxine Sodium	396	31,902	$5,458
Risedronate Sodium	Risedronate Sodium	39	3,474	$4,562

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0630	Patient lift, hydraulic or mechanical, includes any seat, sling, strap(s) or pad(s)	Y	N/R	14	$631

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	1	$87	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Laura Rosner, M.D.?

Tedicare shows public-source Medicare data for Laura Rosner, M.D. (NPI 1427085752), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Rosner, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura Rosner, M.D.?

Laura Rosner, M.D. is linked to TALLAHASSEE MEDICAL GROUP, PLLC (billing NPI 1972265130) in the available physician profile data.

Does Laura Rosner, M.D. have Open Payments data?

Laura Rosner, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.